2821 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page
of 57 | next »
IH abundance (Normal Tissue)
x
RNA abundance (Normal Tissue)
x
A1BG Alpha-1-B glycoprotein
Liver cancer: 3.97e-4 Tissue enriched 297 liver: 505.4
A2M Alpha-2-macroglobulin
Expressed in all
A2ML1 Alpha-2-macroglobulin-like 1
Tissue enriched 6 esophagus: 480.8
A4GNT Alpha-1,4-N-acetylglucosaminyltransferase
Tissue enriched 8 stomach: 24.6
AAGAB Alpha- and gamma-adaptin binding protein
Nuclear speckles Cytosol Renal cancer: 1.36e-4 Thyroid cancer: 9.48e-4 Expressed in all
AANAT Aralkylamine N-acetyltransferase
Cytosol Tissue enhanced testis: 4.8
ABCA6 ATP-binding cassette, sub-family A (ABC1), member 6
Nucleoplasm Liver cancer: 3.29e-4 Tissue enhanced liver: 41.4
ABCA7 ATP-binding cassette, sub-family A (ABC1), member 7
Golgi apparatus Plasma membrane Cell Junctions Endometrial cancer: 1.12e-4 Colorectal cancer: 7.26e-4 Mixed
ABCG1 ATP-binding cassette, sub-family G (WHITE), member 1
Golgi apparatus Vesicles Renal cancer: 7.16e-6 Expressed in all
ABHD1 Abhydrolase domain containing 1
Tissue enriched 17 testis: 29.9
ABHD10 Abhydrolase domain containing 10
Mitochondria Renal cancer: 4.72e-9 Cervical cancer: 7.57e-4 Expressed in all
ABHD14A Abhydrolase domain containing 14A
Vesicles Lung cancer: 4.72e-4 Expressed in all
ABHD15 Abhydrolase domain containing 15
Nucleoplasm Cytosol Mixed
ABHD17A Abhydrolase domain containing 17A
Vesicles Pancreatic cancer: 1.76e-5 Endometrial cancer: 1.73e-4 Head and neck cancer: 6.46e-4 Mixed
ABHD17B Abhydrolase domain containing 17B N/A
Renal cancer: 2.59e-4 Expressed in all
ABI3BP ABI family, member 3 (NESH) binding protein
Nucleoli Nuclear speckles Centrosome Cytosol Renal cancer: 6.14e-4 Mixed
ABLIM1 Actin binding LIM protein 1
Cytosol Renal cancer: 2.72e-5 Expressed in all
ABR Active BCR-related
Nucleoplasm Cytosol Renal cancer: 2.21e-4 Cervical cancer: 4.03e-4 Mixed
AC009133.22 N/A
Tissue enhanced colon: 2.7 duodenum: 1.9 spleen: 1.0
AC011513.3
Group enriched 7 colon: 42.9 esophagus: 10.4
AC136352.5 N/A
Not detected
ACACB Acetyl-CoA carboxylase beta
Renal cancer: 1.15e-5 Pancreatic cancer: 1.93e-4 Tissue enriched 6 adipose tissue: 194.0
ACAD9 Acyl-CoA dehydrogenase family, member 9
Mitochondria Renal cancer: 4.32e-8 Liver cancer: 3.67e-6 Endometrial cancer: 3.05e-4 Expressed in all
ACADS Acyl-CoA dehydrogenase, C-2 to C-3 short chain
Nucleoplasm Mitochondria Renal cancer: 3.33e-6 Urothelial cancer: 6.34e-5 Liver cancer: 2.43e-4 Endometrial cancer: 5.05e-4 Glioma: 9.94e-4 Expressed in all
ACADVL Acyl-CoA dehydrogenase, very long chain
Nucleus Nucleoli Mitochondria Pancreatic cancer: 6.87e-4 Expressed in all
ACAN Aggrecan
Renal cancer: 1.47e-6 Tissue enhanced seminal vesicle: 5.0
ACAT1 Acetyl-CoA acetyltransferase 1
Mitochondria Renal cancer: 0.00e+0 Liver cancer: 1.43e-5 Expressed in all
ACE Angiotensin I converting enzyme
Vesicles Tissue enhanced duodenum: 183.8 small intestine: 297.5
ACHE Acetylcholinesterase (Yt blood group)
Golgi apparatus Vesicles Renal cancer: 3.88e-5 Glioma: 7.16e-4 Tissue enhanced skeletal muscle: 58.5
ACOT9 Acyl-CoA thioesterase 9
Nucleoplasm Plasma membrane Cytosol Liver cancer: 3.23e-4 Expressed in all
ACOX3 Acyl-CoA oxidase 3, pristanoyl
Peroxisomes Endometrial cancer: 2.16e-4 Expressed in all
ACOXL Acyl-CoA oxidase-like N/A
Nucleoli Cytosol Urothelial cancer: 6.48e-4 Group enriched 5 epididymis: 9.2 lung: 14.6 parathyroid gland: 7.4 prostate: 5.5 testis: 5.3 urinary bladder: 8.0
ACP5 Acid phosphatase 5, tartrate resistant
Cytosol Tissue enhanced lung: 254.2
ACP6 Acid phosphatase 6, lysophosphatidic N/A
Urothelial cancer: 6.44e-4 Expressed in all
ACPP Acid phosphatase, prostate
Tissue enriched 153 prostate: 6368.2
ACR Acrosin
Tissue enriched 56 testis: 115.9
ACRBP Acrosin binding protein
Nucleoplasm Vesicles Tissue enriched 19 testis: 432.6
ACRV1 Acrosomal vesicle protein 1
Tissue enriched 37 testis: 152.8
ACSF2 Acyl-CoA synthetase family member 2
Nucleoplasm Microtubules Cytosol Renal cancer: 2.17e-4 Urothelial cancer: 2.41e-4 Tissue enhanced kidney: 136.1
ACSM3 Acyl-CoA synthetase medium-chain family member 3
Renal cancer: 9.88e-6 Ovarian cancer: 1.97e-4 Tissue enhanced liver: 93.0
ACVR1 Activin A receptor, type I
Urothelial cancer: 5.17e-4 Expressed in all
ACVR1C Activin A receptor, type IC
Tissue enriched 8 adipose tissue: 33.9
ACVRL1 Activin A receptor type II-like 1
Tissue enhanced placenta: 125.5
ACYP1 Acylphosphatase 1, erythrocyte (common) type
Nucleus Cytosol Liver cancer: 6.14e-7 Breast cancer: 1.17e-4 Expressed in all
ACYP2 Acylphosphatase 2, muscle type
Nucleoplasm Expressed in all
ADAM10 ADAM metallopeptidase domain 10
Vesicles Plasma membrane Lung cancer: 8.46e-5 Pancreatic cancer: 1.90e-4 Expressed in all
ADAM12 ADAM metallopeptidase domain 12
Plasma membrane Renal cancer: 2.39e-14 Tissue enriched 8 placenta: 236.1
ADAM15 ADAM metallopeptidase domain 15
Vesicles Renal cancer: 5.64e-9 Glioma: 3.49e-5 Liver cancer: 3.49e-4 Expressed in all
ADAM17 ADAM metallopeptidase domain 17
Cytosol Urothelial cancer: 4.23e-5 Expressed in all
ADAM22 ADAM metallopeptidase domain 22
Cell Junctions Tissue enhanced cerebral cortex: 47.7
Page
of 57 | next »